No Images? View online   |   Forward to a friend

Discover new trends, technologies and solutions for your most pressing quality control situations through our QC Corner. Covering topics from drug development, to manufacturing, and regulatory guidance, our QC Corner features a variety of content from industry thought leaders, consultants, regulatory agencies and industry suppliers.

QC Corner offers content through a mix of articles, webinars, and videos all specifically chosen to increase your knowledge and understanding of the latest strategies for pharmaceutical quality control and assurance.

ARTICLE

BIOBALL Burkholderia cepacia Complex Strains Performance Testing for USP <60> Growth Promotion...

Over the years, presence of objectionable microorganisms has been identified as the leading cause of non-sterile drug... Learn More

Q&A

QC Executive Q&A - Research and Development of Protein-Based Therapeutics

As a global provider, MilliporeSigma offers a wide range of products and services to biopharma. On the analytical side...Download Now

WHITE PAPER

Key Considerations for Extracting Proteins from Recombinant Host Cells

In the biopharmaceutical industry, quality is pivotal. For a final product to meet quality standards, quality must...Download Now

WHITE PAPER

Purification Strategies for Recombinant Therapeutic Proteins

Many biopharmaceuticals are recombinant proteins obtained by biotechnological processes. In various steps... Download Now

WEBINAR

Robotics and Automation: The Future of Pharma QC

The pharmaceutical industry is evolving towards automated, intensified and real-time-monitored production processes...Watch Now

ARTICLE

Middle-Up Strategies for Monoclonal Antibodies

The pharmaceutical industry is evolving towards automated, intensified and real-time-monitored production processes...Read Now

American Pharmaceutical Review
395 Oyster Point Blvd., Suite 300,
South San Francisco, CA 94080 USA

To ensure delivery to your inbox, please add newsletters@aprpub.com to your address book. This information is being brought to you because you are a subscriber to American Pharmaceutical Review.

Manage your Subscription  |   Unsubscribe